W. Shipley

1.0k total citations · 1 hit paper
14 papers, 739 citations indexed

About

W. Shipley is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology. According to data from OpenAlex, W. Shipley has authored 14 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 5 papers in Radiation and 4 papers in Oncology. Recurrent topics in W. Shipley's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Advanced Radiotherapy Techniques (5 papers). W. Shipley is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Advanced Radiotherapy Techniques (5 papers). W. Shipley collaborates with scholars based in United States and Canada. W. Shipley's co-authors include Mack Roach, Richard K. Valicenti, C.A. Lawton, Michael J. Seider, Sucha O. Asbell, Charles R. Thomas, Mitchell Machtay, Michelle DeSilvio, Sangwon Han and Marvin Rotman and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Veterinary Record.

In The Last Decade

W. Shipley

14 papers receiving 716 citations

Hit Papers

Phase III Trial Comparing Whole-Pelvic Versus Prostate-On... 2003 2026 2010 2018 2003 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413
    2003 471 citations Mack Roach, Michelle DeSilvio et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Shipley United States 8 625 349 152 107 85 14 739
Nabil El Hage Chehade United States 14 483 0.8× 170 0.5× 107 0.7× 54 0.5× 71 0.8× 40 654
A. Losa Italy 15 314 0.5× 39 0.1× 373 2.5× 60 0.6× 95 1.1× 36 692
David R. Paolone United States 8 202 0.3× 78 0.2× 87 0.6× 16 0.1× 135 1.6× 11 469
Makoto Kurai Japan 11 285 0.5× 24 0.1× 114 0.8× 41 0.4× 36 0.4× 41 469
Carlos A. Jimenez United States 15 524 0.8× 20 0.1× 120 0.8× 88 0.8× 14 0.2× 26 589
Gregory P. Thibault United States 9 230 0.4× 7 0.0× 113 0.7× 30 0.3× 86 1.0× 13 323
Paul Carpentier Belgium 11 369 0.6× 5 0.0× 307 2.0× 16 0.1× 96 1.1× 16 596
Osama Zaytoun United States 10 412 0.7× 5 0.0× 114 0.8× 49 0.5× 155 1.8× 35 485
Manuela Coe Italy 9 164 0.3× 12 0.0× 139 0.9× 100 0.9× 33 0.4× 13 405

Countries citing papers authored by W. Shipley

Since Specialization
Citations

This map shows the geographic impact of W. Shipley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Shipley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Shipley more than expected).

Fields of papers citing papers by W. Shipley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Shipley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Shipley. The network helps show where W. Shipley may publish in the future.

Co-authorship network of co-authors of W. Shipley

This figure shows the co-authorship network connecting the top 25 collaborators of W. Shipley. A scholar is included among the top collaborators of W. Shipley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Shipley. W. Shipley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ebrahim, Hassan Y., et al.. (2015). Inflammatory metastatic breast cancer with gallbladder metastasis: an incidental finding. The Journal of Community and Supportive Oncology. 13(7). 256–259. 1 indexed citations
2.
Dinney, Colin P., Donna E. Hansel, David J. McConkey, et al.. (2014). Novel neoadjuvant therapy paradigms for bladder cancer: Results from the National Cancer Center Institute Forum. Urologic Oncology Seminars and Original Investigations. 32(8). 1108–1115. 22 indexed citations
3.
Lawton, C.A., Jeff M. Michalski, Issam El Naqa, et al.. (2008). Variation in the Definition of Clinical Target Volumes for Pelvic Nodal Conformal Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 74(2). 377–382. 59 indexed citations
4.
Valicenti, Richard K., Michelle DeSilvio, G. Hanks, et al.. (2005). Surrogate endpoint for prostate cancer-specific survival: Validation from an analysis of Radiation Therapy Oncology Group Protocol 92–02. Journal of Clinical Oncology. 23(16_suppl). 4549–4549. 3 indexed citations
5.
Chakravarti, Arnab, Michelle DeSilvio, M. Zhang, et al.. (2005). The Prognostic Value of p16 Expression in Locally Advanced Prostate Cancer: A Study Based on RTOG 92-02. International Journal of Radiation Oncology*Biology*Physics. 63. S17–S18. 1 indexed citations
6.
Coen, John J., Yu Suzuki, Chin‐Lee Wu, et al.. (2005). VEGF-D expression predicts biochemical outcome in localized prostate cancer treated with external radiation: A ten-year cohort analysis. Journal of Clinical Oncology. 23(16_suppl). 9660–9660. 2 indexed citations
7.
Roach, Mack, Michelle DeSilvio, Charles R. Thomas, et al.. (2004). Progression free survival (PFS) after whole-pelvic (WP) vs. mini-pelvic (MP) or prostate only (PO) radiotherapy (RT): A subset analysis of RTOG 9413, a Phase III prospective randomized trial using neoadjuvant and concurrent (N&CHT). International Journal of Radiation Oncology*Biology*Physics. 60(1). S264–S265. 18 indexed citations
8.
Roach, Mack, Kathryn Winter, Jeffrey Michalski, et al.. (2004). Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study. International Journal of Radiation Oncology*Biology*Physics. 60(5). 1351–1356. 98 indexed citations
9.
Roach, Mack, Michelle DeSilvio, C.A. Lawton, et al.. (2003). Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413. Journal of Clinical Oncology. 21(10). 1904–1911. 471 indexed citations breakdown →
10.
Kupelian, Patrick A., Howard D. Thames, Lawrence B. Levy, et al.. (2003). Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. International Journal of Radiation Oncology*Biology*Physics. 57(2). S271–S272. 7 indexed citations
11.
Zietman, Anthony L., et al.. (2002). Freedom from castration: an alternative end point for men with localized prostate cancer treated by external beam radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 53(5). 1152–1159. 3 indexed citations
12.
Roach, Mack, Jiandong Lu, C.A. Lawton, et al.. (2001). A phase III trial comparing whole-pelvic (WP) to prostate only (PO) radiotherapy and neoadjuvant to adjuvant total androgen suppression (TAS): preliminary analysis of RTOG 9413. International Journal of Radiation Oncology*Biology*Physics. 51(3). 3–3. 31 indexed citations
13.
Shipley, W., Howard D. Thames, G. Hanks, et al.. (1998). PSA failure free survival following irradiation for stage T1–T2 prostate cancer patients: The results of an ASTRO sponsored pooled analysis. International Journal of Radiation Oncology*Biology*Physics. 42(1). 176–176. 2 indexed citations
14.
Huang, Jia, et al.. (1983). Isolation of coronavirus-like agent from horses suffering from acute equine diarrhoea syndrome. Veterinary Record. 113(12). 262–263. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nabil El Hage Chehade Breakdown of academic impact, for papers by A. Losa Breakdown of academic impact, for papers by David R. Paolone Breakdown of academic impact, for papers by Makoto Kurai Breakdown of academic impact, for papers by Carlos A. Jimenez Breakdown of academic impact, for papers by Gregory P. Thibault Breakdown of academic impact, for papers by Paul Carpentier Breakdown of academic impact, for papers by Osama Zaytoun Breakdown of academic impact, for papers by Manuela Coe
Rankless by CCL
2026